Brain-specific proteins in the cerebrospinal fluid of severely asphyxiatednewborn infants

Citation
M. Blennow et al., Brain-specific proteins in the cerebrospinal fluid of severely asphyxiatednewborn infants, ACT PAEDIAT, 90(10), 2001, pp. 1171-1175
Citations number
17
Categorie Soggetti
Pediatrics,"Medical Research General Topics
Journal title
ACTA PAEDIATRICA
ISSN journal
08035253 → ACNP
Volume
90
Issue
10
Year of publication
2001
Pages
1171 - 1175
Database
ISI
SICI code
0803-5253(200110)90:10<1171:BPITCF>2.0.ZU;2-K
Abstract
Upcoming trials of neuroprotective strategies in severely asphyxiated newbo rn infants emphasize the need for early and objective markers of both good and bad long-term prognosis. Traditional markers such as neurological depre ssion and seizures are not specific. Aim: To study whether measurement in t he cerebrospinal fluid of some proteins known to be specific to the central nervous system was in covariance with the clinical course and long-term pr ognosis. Methods: Twenty-two asphyxiated infants were included in the study and compared with a control group of 8 infants without signs of perinatal asphyxia. Cerebrospinal fluid (CSF) was collected during the first 4 d of l ife and analysed for neurofilament protein (NFp), glial fibrillary acidic p rotein (GFAp), protein S-100 and neuron-specific enolase (NSE). Results: Th e concentrations of all four proteins were significantly increased in the C SF of asphyxiated infants. The concentrations correlated significantly with other indicators of long-term prognosis and to neurological impairment at 1 y of age, or death before that time. Specifically, concentrations were ex cessively high in the five infants who died. Conclusions: High concentrations of brain-specific proteins are released in to the CSF of asphyxiated infants. It might therefore be useful to measure these concentrations when excluding patients with the gravest prognosis fro m neuroprotective trials.